DV
Dividend Vision

IONS — Ionis Pharmaceuticals Inc.

Ionis Pharmaceuticals Inc. (IONS)

Its deepest 1-year drawdown was 40.2%.

This appears to be an individual stock rather than an ETF—Ionis Pharmaceuticals Inc. is a biopharmaceutical company focused on RNA-targeted therapeutics. The company distributes earnings bi-monthly, though specific yield and expense ratio data are not available. Income from this holding would appeal primarily to investors seeking exposure to the pharmaceutical sector combined with regular distributions, though individual stock holdings carry concentrated risk compared to diversified ETF portfolios.

IONS key facts

Asset type
Stock
Asset class
Equity
Inception date
05/17/1991
Distribution frequency
Bi-Monthly
Last close
$57.24
Market cap
$9,512,390,656
Average volume
1353737.0
Last dividend
$0.1100
Beta
0.4
Payout ratio
0.0
Forward P/E
90.9091
EPS
$-3.48